Skip to content

Infanrix Penta – Summary of Product Characteristics (SmPC) for healthcare professionals

Contains active substance:: Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain)), hepatitis B surface antigen
ATC code:: J07CA12 diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
Similar medicines?:: Vaxelis suspension for injection in Pre-filled syringe

Tritanrix HepB

Quintanrix

Tetravac suspension for injection, Diphtheria Tetanus Pertussis (Acellular Component) and Poliomyelitis (Inactivated) vaccine

Procomvax

Hexyon

Hexacima

Summary of Product Characteristics (SmPC) - Infanrix Penta

Sources: Original PDF (ema.europa.eu)

The drug is classified in the ATC tree:

J Antiinfectives for systemic use

J07C Bacterial and viral vaccines, combined

J07CA Bacterial and viral vaccines, combined

J07CA12 diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B